MetaCap

ALPS Medical Breakthroughs ETF (SBIO)

NYSEARCA: SBIOALPSHealthETFUSD

55.04+1.10 (+2.03%)

At close: Oct 9, 3:59 PM ET · Delayed 15 min

SBIO chart

Full chart

Key facts

Expense ratio
0.50%
Assets (AUM)
$211.56M
Dividend yield
—
Holdings
10
Inception
Dec 30, 2014
Issuer
ALPS
Index tracked
—
Category
Health
52-week range
40.57 – 70.85
Volume / Avg
33.63K / 41.47K
Beta
—
Previous close
53.95

SBIO ETF today

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund from ALPS in the Health category. It charges an expense ratio of 0.50%, or $50.00 per year on a $10,000 investment, and manages $211.6 million in assets. Its largest holding is CG Oncology Inc (CGON) at 3.94% of assets, and the top 10 positions make up 30.2% of the portfolio out of 10 holdings.

SBIO launched on Dec 30, 2014.

Summary generated from market data by MetaCap's automated system. Methodology

SBIO top 10 holdings

SBIO holdings by weight
#HoldingWeight
1CGONCG Oncology Inc3.94%
2TVTXTravere Therapeutics Inc Ordinary Shares3.48%
3ORKAOruka Therapeutics Inc3.45%
4DFTXDefinium Therapeutics Inc Ordinary Shares3.20%
5MANEVeradermics Inc3.17%
6DNTHDianthus Therapeutics Inc3.08%
7EWTXEdgewise Therapeutics Inc2.76%
8RLAYRelay Therapeutics Inc Ordinary Shares2.48%
9IDYAIDEAYA Biosciences Inc2.32%
10AMLXAmylyx Pharmaceuticals Inc2.29%

Top 10 holdings: 30.2% of assets.

SBIO performance

1 week

+1.68%

SBIO price return, excluding dividends.

ETFs similar to SBIO

SPYState Street SPDR S&P 500 ETF Trust778.57 +0.60%VOOVanguard S&P 500 ETF715.59 +0.61%IVViShares Core S&P 500 ETF781.97 +0.60%RSPInvesco S&P 500 Equal Weight ETF213.04 +0.55%

SBIO ETF FAQ

What is the SBIO price today?

SBIO last traded at $55.04 as of Oct 9, 3:59 PM EDT, up 2.03% on the day.

What is SBIO's expense ratio?

SBIO has an expense ratio of 0.50%, which works out to about $50.00 per year for every $10,000 invested.

What are SBIO's top holdings?

SBIO's largest holdings are CG Oncology Inc (3.94%), Travere Therapeutics Inc Ordinary Shares (3.48%), Oruka Therapeutics Inc (3.45%), Definium Therapeutics Inc Ordinary Shares (3.20%), Veradermics Inc (3.17%). The top 10 make up 30.2% of the fund.

How big is SBIO?

SBIO has about $211.6 million in assets under management spread across 10 holdings.

Explore